{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Covington",
      "address_1": "8195 Industrial Blvd NE",
      "reason_for_recall": "Activity and quantity of seeds sent in shipments were incorrect.",
      "address_2": "",
      "product_quantity": "134 seeds",
      "code_info": "Product Code: 1251QCSCE, Lot No. BBAY0072, BBAY0079, BBAY0090, BBAY0071, BBAY0073.",
      "center_classification_date": "20171220",
      "distribution_pattern": "Belgium & South Africa.",
      "state": "GA",
      "product_description": "I-125 CE Marked QuickLink Cartridges; Sterile; Bard Brachysource Radioactive Seeds in QuickLink Cartridges    Indicated for permanent interstitial treatment of selected localized tumors such as: head and neck, lung, pancreas, and early stage prostate. Implants are indicated to treat residual tumors following completion of a course of external radiation therapy and for recurrent tumors.",
      "report_date": "20171227",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "C.R. Bard, Inc.",
      "recall_number": "Z-0267-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "77439",
      "termination_date": "20200424",
      "more_code_info": "",
      "recall_initiation_date": "20161209",
      "postal_code": "30014-1497",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}